48 unknown. 48 Phase 1, 24 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 48 | Unknown 48 |
| Phase 2 | 24 | Unknown 24 |
Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants H021, H021 Placebo - Ulcerative Colitis | Phase 1 | Unknown | Jiangsu Carephar Pharmaceutical Co., Ltd. | 64 | 2024-09-17 | 2024-10-04 |
| Beta-Hydroxybutyrate Feasibility Treating IBD Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's - Crohn's Disease, Inflammatory Bowel Diseases | Phase 1 / Phase 2 | Unknown | University of Texas at Austin | 20 | 2024-08-28 | 2024-09-19 |
| Evaluate the Distribution and Dynamic Behavior of TH-SC01 Cells in Vivo in Patients With Perianal Fistula Mesenchymal Stem Cells (MSCs) - Anal Fistula, Complex Perianal Fistulas | Phase 1 | Unknown | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | 8 | 2024-04-08 | 2024-06-12 |
| Fecal Transplantation in Patients Colonic Diverticulitis Fecal Microbiome, Placebo - Diverticulitis, Colonic, Colon Inflamed | Phase 1 | Unknown | Odense University Hospital | 40 | 2024-04-01 | 2024-04-05 |
| Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease Adalimumab-680LT, Control - Crohn Disease, Ulcerative Colitis | Phase 1 / Phase 2 | Unknown | University Medical Center Groningen | 21 | 2024-03-01 | 2024-03-12 |
| A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects HRS-7085 Tablets, HRS-7085 simulant - Inflammatory Bowel Disease | Phase 1 | Unknown | Shandong Suncadia Medicine Co., Ltd. | 70 | 2023-12-01 | 2023-12-19 |
| Pilot Study of a New Medical Food in the Management of Ulcerative Colitis Soluble protein hydrolysate (SPHi) - Ulcerative Colitis | Phase 1 | Unknown | Stanford University | 25 | 2023-12-01 | 2023-11-03 |
| A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis APL-1401, Placebo - Ulcerative Colitis | Phase 1 | Unknown | Jiangsu Yahong Meditech Co., Ltd aka Asieris | 36 | 2023-01-26 | 2023-09-06 |
| Transversus Abdominis Plane Blocks With and Without Dexamethasone Dexamethasone - Colorectal Disorders, Regional Anesthesia Morbidity | Phase 1 / Phase 2 | Unknown | University of Saskatchewan | 60 | 2022-09-01 | 2023-12-07 |
| Treg Immunotherapy in Crohn's Disease TR004 (Treg immunotherapy) - Crohn Disease | Phase 1 | Unknown | King's College London | 4 | 2022-08-08 | 2023-01-31 |
| Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy personalized exclusion diet based on CLE, empiric exclusion diet - Eosinophilic Esophagitis | Phase 1 / Phase 2 | Unknown | Universitaire Ziekenhuizen KU Leuven | 25 | 2022-02-16 | 2024-06-27 |
| Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis Cobitolimod 500mg - Ulcerative Colitis | Phase 1 | Unknown | InDex Pharmaceuticals | 6 | 2021-11-22 | 2022-06-10 |
| GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery GM-CSF, fosfomycin and metronidazole - Pouchitis | Phase 1 / Phase 2 | Unknown | Zealand University Hospital | 18 | 2021-09-06 | 2023-01-26 |
| A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease fecal microbiota capsule - Inflammatory Bowel Disease, Ulcerative Colitis Type | Phase 1 | Unknown | Zhongshan Hospital Xiamen University | 200 | 2020-12-01 | 2023-11-14 |
| A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease. TH-SC01 - Crohn's Disease | Phase 1 | Unknown | Jinling Hospital, China | 24 | 2020-11-12 | 2021-06-25 |
| Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO Inhaled Nitric Oxide, Placebo - Anemia | Phase 1 / Phase 2 | Unknown | New York Medical College | 50 | 2019-02-06 | 2019-04-24 |
| Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis Adipose-cord mesenchymal stromal cells (A-MSCs), Conventional drugs - Ulcerative Colitis (UC) | Phase 1 / Phase 2 | Unknown | Liaocheng People's Hospital | 50 | 2018-07-01 | 2020-09-02 |
| [KJ-INT-002] BE Study INT-2150, Irsogladine maleate 2 mg+Nizatidine 150 mg - Gastritis | Phase 1 | Unknown | Kukje Pharma | 37 | 2017-11-02 | 2018-04-26 |
| Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease Wharton Jelly Mesenchymal stem cells - Inflammatory Bowel Diseases | Phase 1 / Phase 2 | Unknown | Hanan Jafar | 20 | 2017-06-05 | 2019-04-10 |
| Phaseâ… First-in-Human Study of Hemay007 in Healthy Volunteers Hemay007, placebo - Inflammatory Bowel Disease | Phase 1 | Unknown | Hemay Pharmaceutical PTY. LTD. | 82 | 2017-01-09 | 2017-10-24 |
Showing 20 of 48. Sign in to see all of them.
Colitis, Ulcerative (18) · Crohn Disease (14) · Inflammatory Bowel Diseases (8) · Enterocolitis, Necrotizing (4) · Diverticular Diseases (3) · Agnosia (2) · Appendicitis (2) · Colorectal Neoplasms (2) · Inflammation (2) · Anemia (1) · Anemia, Aplastic (1) · Anemia, Neonatal (1) · Barrett Esophagus (1) · Bronchopulmonary Dysplasia (1) · Campylobacter Infections (1)
Digestive System Diseases (48) · Gastrointestinal Diseases (48) · Intestinal Diseases (42) · Inflammatory Bowel Diseases (25) · Colonic Diseases (22) · Colitis (18) · Pathological Conditions, Signs and Symptoms (8) · Enterocolitis (5) · Neoplasms (5) · Hemic and Lymphatic Diseases (4) · Infections (4) · Pathologic Processes (4) · Digestive System Neoplasms (3) · Gastrointestinal Neoplasms (3)
Fecal Microbiota Transplantation (2) · Saline Solution (2) · 2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid (1) · Aminolevulinic Acid (1) · Appendectomy (1) · Dexamethasone (1) · Drug Therapy (1) · Esomeprazole (1) · Fosfomycin (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · In Vitro Techniques (1) · Injections, Epidural (1) · Mesalamine (1) · Mesenchymal Stem Cell Transplantation (1) · Metronidazole (1)
Rania Ali El-Farrash (2) · Affiliated Hospital to Academy of Military Medical Sciences (1) · Anterogen Co., Ltd. (1) · Avidia (1) · Beijing Friendship Hospital (1) · Burnasyan Federal Medical Biophysical Center (1) · Children's Hospital Los Angeles (1) · Fast Forward Pharmaceuticals (1) · First Affiliated Hospital of Chengdu Medical College (1) · Hanan Jafar (1) · Hemay Pharmaceutical PTY. LTD. (1) · Herlev Hospital (1) · InDex Pharmaceuticals (1) · Instituto de Investigación Hospital Universitario La Paz (1) · Jiangsu Carephar Pharmaceutical Co., Ltd. (1)
China (8) · United States (7) · South Korea (4) · Australia (3) · Canada (3) · Denmark (3) · Netherlands (3) · United Kingdom (3) · Belgium (2) · Egypt (2) · Iran (2) · Sweden (2) · Croatia (1) · India (1) · Israel (1)
Rania A El-Farrash, MD (2) · Beth Kirkpatrick, MD (1) · Bing Liu, M.D. (1) · Boguslaw Machalinski, MD, PhD, BSc (1) · David N Ginther, MD (1) · David Tribble, MD (1) · Edmund LaGamma, MD (1) · Fred Konikoff, professor (1) · Gang Zhao, MD (1) · Geert D'Haens, M.D., Ph.D. (1) · Graham Radford-Smith, MD (1) · Hamid Gourabi, PhD (1) · Ilya I Eremin, MD, PhD (1) · Jacek Rudnicki, MD, PhD, BSc (1)
PMID 17560413, PMID 20393336, PMID 22818551, PMID 23292233, PMID 23473061, PMID 23648372, PMID 23840001, PMID 25104129, PMID 25927273, PMID 26340878, PMID 26643677, PMID 29906796, PMID 30366723, PMID 30710527, PMID 31272391, PMID 33188747, PMID 33571293, PMID 37904247, PMID 39758967, PMID 39855667, PMID 40933007, PMID 42728546
2015 (1), 2023 (1)